Jan 13 (Reuters) - Clearwater Analytics Holdings Inc
:
* CLEARWATER ANALYTICS TO ACQUIRE ENFUSION FOR $1.5 BILLION EXPANDING ITS INVESTMENT MANAGEMENT PLATFORM WITH FRONT-TO-BACK CAPABILITIES
* PURCHASE PRICE IS $11.25 PER SHARE IN CASH AND STOCK
* PROPOSED DEAL FOR $11.25 PER SHARE
* TO PAY $30 MILLION TO TERMINATE ENFUSION'S TRA
* ENFUSION EXPECTS 2024 REVENUE OF $201-202 MILLION
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.